Despite conclusive evidence that it’s one of the most dangerous and addictive substances in the world, sugar is still widely used for a variety of purposes. In an effort to curb the effects of this sweet food, substitutes like aspartame have been introduced. Naturally, there were concerns about its supposed effects on health, but a recent study found that there were no causes for concern.
Recently published in The Journal of Nutrition, researchers basically looked into the effects of aspartame on several factors of health. These included glucose tolerance, weight, and appetite. The results indicated that the sugar substitute basically had no negative impact on any of those factors.
“With the exception of the baseline OGTT glucose concentration at 60 min (and resulting area under the curve value), there were no group differences for glucose, insulin, resting leptin, glucagon-like peptide 1, or gastric inhibitory peptide at baseline or week 12,” the results of the study reads. “There also were no effects of aspartame ingestion on appetite, body weight, or body composition.”
The study lasted for 12 weeks from start to finish, and throughout that period, the subjects were divided into three groups. One group took no aspartame while another took 350 mg per day. The third group took a much higher dosage of 1,050 mg of the sugar substitute.
Blood samples were taken from the subjects before the start of the trial and at the end of the 12-week course. Apparently, the participants did not show any significant differences in the factors that the researchers were looking at. In conclusion, the researchers note that their findings do not support the notion that aspartame comes with negative consequences such as obesity and an increase in rates of hunger.
On the other hand, Medical News Bulletin did note that the study received support from Ajinomoto Co., Inc., which produces products such as artificial sweeteners. However, the authors of the study insist that the findings of their aspartame research were not affected by the source of the funds.


Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility? 



